stella
beta
Safety and Efficacy of CD19 CAR-T Therapy for Recurrent/Refractory Autoimmune Diseases — Stella
Recruiting
Back to Autoimmune Disease trials
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(1 site)
China
Beijing Gobroad Brond Hospital, Beijing, Beijing Municipality
View full record on ClinicalTrials.gov